Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery di...

In this episode of Lipid Insights, Dr. Peter Jones and guest Dr. Kevin Maki explore whether beef deserves its long-standing reputation as a driver of cardiovascular disease. Drawing on a recent systematic review and meta-analysis,...

In this short episode, guest host Dr. Dan Soffer chats with Dr. Joshua Hyman, the Young Investigator Award winner at #NLASessions 2025. Dr. Hyman gives a quick overview of his award-winning abstract and shares insights from...

Hosted by Dr. Dan Soffer, this conversation brings NLA President Dr. Willard and Beth Jackson together to unpack the Association’s guidance, “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better.” The trio turns a...

In this episode, Alan Brown, MD, MHA, MNLA sits down with Rebecca Juliano, PhD, MPhil, MA to discuss a first-in-human study of an investigational ANGPTL4 inhibitory antibody. The conversation explores how this novel therapeutic ap...

Explore the NLA’s new guidance on building effective, team-based approaches to improve outcomes in clinical lipidology and cardiometabolic care.Read the Expert Clinical Review

Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific Sessions. Guest host Christie Ballantyne, MD, is joined by leading experts Seyedmohamm...

Alan Brown, MD, FNLA talks with Robert Hegele, MD, FRCPC about the Arrowhead Pharma and their data on Palisade Phase 3.

Alan Brown, MD, FNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"

Alan Brown, MD, FNLA talks with Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA and Kevin C Maki, PhD, CLS, FNLA, FTOS, FACN to discuss Nutrition Interventions for Adults with Dyslipidemia. 

Alan Brown, MD, FNLA talks with Mary Katherine Cheeley, PharmD, FNLA about the persistence of statin underuse i practice.

This episodes turns the tables as NLA's own Dan Soffer pitches the questions to Lipid Insights regular host Alan Brown.

Dr. Alan Brown sits down with Zareen Farukhi, MD, MPH,  Associate Physician at Brigham and Women's Hospital and Instructor at Harvard; and Rachel M. Bond, MD, FACC, System Director for Women's Health at Dignity Health and Assistant Profess...

Dr. Alan Brown sits down with Kim Birtcher, PharmD, Adjunct Clinical Professor at the University of Houston College of Pharmacy to discuss approaches to cardiovascular risk reduction in the age of modern therapies such as PCSK9 inhibitors.

Dr. Alan Brown sits down with the 2020 Donald Hunninghake, MD, Familial Hypercholesterolemia (FH) Abstract Award winner to discuss genetic variations in patients with very high LDL cholesterol including familial hypercholesterolemia.

Join Dr. Alan Brown and Dr. Robert Rosenson as they discuss evinacumab, a new therapeutic option for treating dyslipidemia.

Dr. Alan Brown sits down with Dr. Carl Orringer and Dr. Michael Blaha to take a deeper look at the recent NLA scientific statement on CAC Scoring.